Current Liabilities 更改
Gilead Sciences USD 11.28B 665M 2023-12
RedHill Biopharma USD 28.19M 20.25M 2023-06
Supernus Pharmaceuticals USD 290.2M 2.66M 2023-12



Intra Cellular Therapies 流动负债 - 当前值,历史数据,预测,统计,图表和经济日历 - May 2024.